Evidence map›Paper›PMID 19099276›Full record

ReviewDer Internist2009

[Mucocutaneous infections in immunosuppression].

P H Itin, M Battegay

Erratum issuedOpen access · greenAbstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Internist, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

P H ItinDermatologie, Universitätsspital, Petersgraben 4, 4031, Basel, Deutschland. peter.itin@unibas.ch
M Battegay
University Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The skin has several physical, chemical and immunological properties which help to protect the internal organs. In addition, there is a physiological colonisation of commensal microbes which help to suppress the expansion of pathogenic germs on the skin. Genetic or acquired immunodeficiency will have an impact to these factors. Drug induced immunodeficiency is common in organ transplanted patients with the aim to prevent organ rejection. HIV infection most commonly leads without therapy to marked immune suppression. Such patients with prolonged immunodeficiency often develop atypical manifestation of mucocutaneous infections. Therefore such patients should be biopsied liberally and besides the conventional histology a part of the biopsied tissue should be used for microbiological cultures. In addition to acute infections of the skin, long-term effects of oncogenic viruses have to be taken in account which can lead to epithelial cancers (HPV), Kaposi sarcomas (HHV8) and lymphomas (EBV). There are mucocutaneous markers for immunosuppression such as oral hairy leukoplakia, which are commonly seen in AIDS patients but may also be observed in otherwise chronically immune suppressed patients. This work gives an overview to the pathophysiology of skin protection and describes typical mucocutaneous infections in immune suppressed patients.

Indexed as

Autoimmune DiseasesHumansImmunocompromised HostSkin Diseases, Infectious

Identifiers

PMID19099276
OpenAlexW1564191273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.